Assessment of the influence of synthetic peptide of the active center of granulocyte-macrophagal colony-stimulating factor – ZP2 on the growth properties of Corynebacterium spp.
- Authors: Gritsenko V.A.1, Morozova N.V.1, Gladysheva I.V.1, Cherkasov S.V.1
-
Affiliations:
- Institute of Cellular and Intracellular Symbiosis, Orenburg Federal Research Center, Ural Branch, Russian Academy of Sciences
- Issue: Vol 27, No 3 (2024)
- Pages: 441-448
- Section: SHORT COMMUNICATIONS
- URL: https://bakhtiniada.ru/1028-7221/article/view/267508
- DOI: https://doi.org/10.46235/1028-7221-16862-AOT
- ID: 267508
Cite item
Full Text
Abstract
The goal is to study the effect of the synthetic peptide of the active center of the granulocyte-macrophage coline-stimulating factor ZP2 on the growth properties and biofilm formation of microorganisms of the genus Corynebacterium spp. In vitro experiments were carried out on 13 isolates of Corynebacterium spp., including C. amycolatum (n = 7), C. propinquum (n = 2) and C. pseudodiphtheriticum (n = 4)), previously isolated from healthy individuals and are part of the Network Collection of Symbiotic Microorganisms and Their Consortia of the Institute for Cellular and Intracellular Symbiosis UrB RAS (Orenburg, Russia). The effect of different concentrations of the ZP2 peptide on the growth properties (planktonic culture growth and biofilm formation) of test strains was assessed in 96-well polystyrene plates. The inhibitory effect of the ZP2 peptide on the growth of planktonic culture was assessed by the Inhibition Index (%), on biofilm formation – by the Degree of Inhibition of Biofilm Formation (%). It was experimentally established that after 2, 4, 6 and 24 hours, a dose-dependent inhibition of the growth of planktonic cultures of all studied bacterial strains was observed under the influence of various concentrations of ZP2 (0.5-2.0 μg/ml). In this case, the inhibitory effect of the ZP2 peptide depended both on its concentration in the cultivation medium and on the growth phase of the test strain of bacteria. The maximum inhibition of the growth of planktonic culture of all studied bacterial strains under the influence of various concentrations of the ZP2 peptide was observed after 24 hours and ranged from 89.3±1.9 to 94.1±1.8% in C. amycolatum, and in C. propinquum from 90.0±0.6 to 96.7±0.3%, in C. pseudodiphtheriticum from 92.2±2.1 to 95.1±1.3. The ZP2 peptide also had a significant effect on biofilm formation in all test cultures studied. The reduction in biofilm formation depended on the concentration of the peptide and ranged from 62.4 to 78.4% in C. amycolatum, from 70.9 to 79.6% in C. propinquum, and from 76 to 82.7% in C. pseudodiphtheriticum.
Thus, the antibacterial effect of the ZP2 peptide was revealed against the studied strains of corynebacteria species C. amycolatum, C. propinquum and C. pseudodiphtheriticum. According to available data, the ZP2 peptide is a drug with a wide spectrum of action that has an inhibitory effect not only on the studied actinobacteria, but also, according to literature data, on staphylococci and enterobacteria. An important prospect of the study is to reveal the mechanism of the antibacterial action of the ZP2 peptide with the characteristics of the effective concentration of the substance against pathogens and representatives of normal flora.
Full Text
##article.viewOnOriginalSite##About the authors
V. A. Gritsenko
Institute of Cellular and Intracellular Symbiosis, Orenburg Federal Research Center, Ural Branch, Russian Academy of Sciences
Author for correspondence.
Email: vag59@mail.ru
PhD, MD (Medicine), Professor, Chief Research Associate, Laboratory of Persistence and Symbiosis of Microorganisms
Russian Federation, OrenburgN. V. Morozova
Institute of Cellular and Intracellular Symbiosis, Orenburg Federal Research Center, Ural Branch, Russian Academy of Sciences
Email: vag59@mail.ru
PhD (Biology), Research Associate, Laboratory of Persistence and Symbiosis of Microorganisms
Russian Federation, OrenburgI. V. Gladysheva
Institute of Cellular and Intracellular Symbiosis, Orenburg Federal Research Center, Ural Branch, Russian Academy of Sciences
Email: vag59@mail.ru
PhD (Medicine), Senior Research Associate, Laboratory of Biomedical Technologies
Russian Federation, OrenburgS. V. Cherkasov
Institute of Cellular and Intracellular Symbiosis, Orenburg Federal Research Center, Ural Branch, Russian Academy of Sciences
Email: vag59@mail.ru
PhD, MD (Medicine), Corresponding Member, Russian Academy of Sciences
Russian Federation, OrenburgReferences
- Бухарин О.В., Гриценко В.А. Влияние in vitro препарата лейкоцитарного катионного белка «Интерцид» на Escherichia coli // Антибиотики и химиотерапия, 2000. № 45 (1). C. 16-20. [Bukharin O.V., Gritsenko V.A. In vitro influence of the leukocyte cationic protein drug “Intertsid” on Escherichia coli. Antibiotiki i khimioterapiya = Antibiotics and Chemotherapy, 2000, no. 45 (1), pp. 16-20. (In Russ.)]
- Гриценко В.А., Тяпаева Я.В., Добрынина М.А., Зурочка А.В. Сравнительный анализ бактерицидных свойств синтетического пептида активного центра ГМ-КСФ – ZP2 в отношении грамотрицательных бактерий разной таксономической принадлежности // Российский иммунологический журнал, 2021. Т. 24, № 2. С. 221-228. [Gritsenko V.A., Tyapaeva Ya.V., Dobrynina M.A., Zurochka A.V. Comparative analysis of the bactericidal properties of the synthetic peptide of the active center of GM-CSF – ZP2 in relation to gram-negative bacteria of different taxonomic affiliations. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2021, Vol. 24, no. 2, pp. 221-228. (In Russ.)] doi: 10.46235/1028-7221-1016-CAO.
- Добрынина М.А., Зурочка А.В., Тяпаева Я.В., Белозерцева Ю.П., Гриценко В.А. Оценка влияния синтетического пептида активного центра гранулоцитарно-макрофагального колониестимулирующего фактора – ZP2 на рост и биопленкообразование клинических изолятов энтеробактерий in vitro // Бюллетень Оренбургского научного центра УрО РАН, 2018. № 4. 17 c. [Dobrynina M.A., Zurochka A.V., Tyapaeva Ya.V., Belozertseva Yu.P., Gritsenko V.A. Assessment of the influence of the synthetic peptide of the active center of the granulocyte-macrophage colony-stimulating factor – ZP2 on the growth and biofilm formation of clinical isolates of enterobacteria in vitro. Byulleten Orenburgskogo nauchnogo tsentra UrO RAN = Bulletin of the Orenburg Scientific Center of the Ural Branch of the Russian Academy of Sciences, 2018, no. 4, 17 p. (In Russ.)]
- Зурочка А.В., Гриценко В.А., Зурочка В.А., Добрынина М.А., Черешнев В.А. Гранулоцитарно-макрофагальный колониестимулирующий фактор (ГМ-КСФ) и его синтетические аналоги: иммунобиологические эффекты и клиническое применение. Екатеринбург: УрО РАН, 2021. 288 с. [Zurochka A.V., Gritsenko V.A., Zurochka V.A., Dobrynina M.A., Chereshnev V.A. Granulocyte-macrophage colony stimulating factor (GM-CSF) and its synthetic analogues: immunobiological effects and clinical application]. Yekaterinburg: Ural Branch of the Russian Academy of Sciences, 2021. 288 p.
- Зурочка А.В., Добрынина М.А., Зурочка В.А., Гриценко В.А. Чувствительность музейных и клинических штаммов энтеробактерий к синтетическому пептиду активного центра ГМ-КСФ – ZP2 // Российский иммунологический журнал, 2020. Т. 23, № 4. С. 403-410. [Zurochka A.V., Dobrynina M.A., Zurochka V.A., Gritsenko V.A. Sensitivity of museum and clinical strains of enterobacteria to the synthetic peptide of the active center of GM-CSF – ZP2. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2020, Vol. 23, no. 4, pp. 403-410. doi: 10.46235/1028-7221-503-SOA.
- Лакин Г.Ф. Биометрия. М.: Высшая школа, 1990. 352 с. [Lakin G.F. Biometrics]. Moscow: Vysshaya shkola, 1990. 352 p.
- Bomar L., Brugger S.D., Yost B.H., Davies S.S., Lemon K.P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio, 2016, Vol. 7, no. 1, e01725-15. doi: 10.1128/mBio.01725-15.
- Graevenitz A., Bernard K. “The genus Corynebacterium-medical” in The Prokaryotes. J. New York, NY: Springer, 2006, pp. 819-842.
- Kataoka N., Vangnai A.S., Pongtharangkul T., Yakushi T., Wada M., Yokota A., Matsushita K. Engineering of Corynebacterium glutamicum as a prototrophic pyruvate-producing strain: characterization of a ramA-deficient mutant and its application for metabolic engineering. J. Biosci. Biotechnol. Biochem., 2019, Vol. 83, no. 2, pp. 372-380.
- Lappan R., Peacock C.S. Corynebacterium and Dolosigranulum: future probiotic candidates for upper respiratory tract infections. Microbiol. Aust., 2019, Vol. 40, no. 4, pp. 172-177. Nicias P. Multifunctional host defense peptides: Intracellular-targeting antimicrobial peptides. FEBS, 2009, Vol. 276, no. 22, pp. 6483-6496.
- Oppenheim J.J., Biragyn A., Kwak L.W., Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis., 2003, no. 62, pp. 17-21.
- Park S-C., Park Y., and Hahm K-S. The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation. Int. J. Mol. Sci., 2011, Vol. 12, no. 9, pp. 5971-5992.
- Pieters R.J., Arnusch C.J., Breukink E. Membrane permeabilization by multivalent anti-microbial peptides. Protein Pept. Lett., 2009, Vol. 16, no. 7, pp. 736-742.
- Stepanovic S., Vukovic D., Hola V., Djukic S., Cirkovic I., Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS, 2007, Vol. 115, no. 8, pp. 891-899.
- Zasada A.A., Mosie E. Contemporary microbiology and identifcation of Corynebacteria spp. causing infections in human. Lett. Appl. Microbiol., 2018, no. 66, pp. 472-483.
- Zasloff M. Antimicrobial peptides of multicellular organisms. Nature, 2002, no. 415 (6870), pp. 389-395.
Supplementary files
